Nice, 27-30/05/2022.
iToBoS project was presented at the conference "Applying AI Privacy Technology in the Healthcare Domain", in the Medical Informatics Europe Congress (MIE 2022).
Nice, 27-30/05/2022.
iToBoS project was presented at the conference "Applying AI Privacy Technology in the Healthcare Domain", in the Medical Informatics Europe Congress (MIE 2022).
Online, 30/05/2022.
An extraordinary General Assembly (GA) meeting took place on 30th May 2022 throughout video conference system with the attendance of 28 participants belonging to the 19 project partner organizations.
Bergamo, 24-25/05/2022.
iToBoS project was presented in Liquid Biopsies Congress 2022 of European Association for Cancer Research (EACR).
Lisbon, 14/05/2022.
iToBoS project was presented in Bootcamp22 Research Strategy workshop in the framework of the Leibniz University Hannover (LUH) work within the project.
Singapore, 6-8/05/2022.
iToBoS project was presented at the conference "Environmental/ host factors and clinical heterogeneity in skin melanoma: the need of a holistic diagnostic tool", in the World Cancer Research Symposium (SCWR 2022).
Porto, 20-23/04/2022.
The iToBoS project was presented at the 1st Spring Biophotonics Conference in Porto (OPORTO22), through the conference titled “Multimodal optical systems for the investigation of skin diseases”.
Barcelona, 31/03/2022.
iToBoS was presented in the framework of a course of the Academia Española de Dermatologia y Venereologia (AEDV) in Barcelona, Spain, on March 31, 2022.
Online, 31/03/2022.
iToBoS project has launched ai4pa (Artificial Intelligence For Patient Advocates) consisting in a training module oriented to patient advocates that serves as an introduction to transparent and explainable AI and its policy context.
Online, 9/03/2022.
The iToBoS 2nd Project Management Board (PMB) meeting took place on 9/03/2022 throughout video conference system with the attendance of 17 attendees.
Barcelona, 28/02 - 8/03, 2022.
iToBoS presents the objectives, challenges and expected benefits of the project at the MWC Open Innovation Challenge 2022 among a wide and multidisciplinary audience.